(2026). Correction: Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK. Cell & Bioscience.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Correction: Dapagliflozin Attenuates Hypoxia/reoxygenation-caused Cardiac Dysfunction and Oxidative Damage Through Modulation of AMPK."
Cell & Bioscience 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Correction: Dapagliflozin Attenuates Hypoxia/reoxygenation-caused Cardiac Dysfunction and Oxidative Damage Through Modulation of AMPK."
Cell & Bioscience, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.